Table 4

Results of base-case analysis for mass screening for Singapore Chinese Males (50–75 years)

Cohort size31482 469
Total no of gastric cancer patients in the cohort7241
ScreenedNot screened
No of subjects217 111265 358
Stage of diagnosis26%: 17%: 24%: 32%18%: 12%: 27%: 43%
Among those compliant to mass screening
 No of miRNA tests done to diagnose one gastric cancer patient489
 No of endoscopes done to diagnose one gastric cancer patient227
 Cost of saving 1 QALY* (US$)44 531
  • *Relative to the current practice of no-screening.

  • miRNA, microRNA; QALY, quality-of-life year.